| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-amylase activity | 4.61e-11 | 5 | 173 | 5 | GO:0004556 | |
| GeneOntologyMolecularFunction | amylase activity | 2.75e-10 | 6 | 173 | 5 | GO:0016160 | |
| GeneOntologyMolecularFunction | chloride ion binding | 1.86e-07 | 16 | 173 | 5 | GO:0031404 | |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 1.71e-06 | 11 | 173 | 4 | GO:0005388 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 4.66e-06 | 144 | 173 | 9 | GO:0016798 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | SMG1 RPS6KA3 LRRK1 CIITA PIK3CB MAP4K1 DCLK3 MAP3K11 TAF1 PRKG2 STK40 MAPK4 MAST3 | 1.76e-05 | 363 | 173 | 13 | GO:0106310 |
| GeneOntologyMolecularFunction | calcium ion binding | NID2 HSPG2 AMY1A AMY1B AMY1C AMY2A AMY2B DSC1 PCDHGA4 PCDHB15 LALBA PCDHAC1 CDH23 IQGAP1 CRB1 CELSR1 NRXN1 SLIT3 ATP2B2 | 2.82e-05 | 749 | 173 | 19 | GO:0005509 |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 3.20e-05 | 103 | 173 | 7 | GO:0004553 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | SMG1 RPS6KA3 LRRK1 CIITA PIK3CB MAP4K1 DCLK3 MAP3K11 TAF1 PRKG2 STK40 MAPK4 MAST3 | 1.43e-04 | 446 | 173 | 13 | GO:0004674 |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 2.58e-04 | 36 | 173 | 4 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 2.58e-04 | 36 | 173 | 4 | GO:0015662 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 3.76e-04 | 109 | 173 | 6 | GO:0042626 | |
| GeneOntologyMolecularFunction | protein kinase activity | SMG1 ABL1 RPS6KA3 LRRK1 CIITA PIK3CB MAP4K1 DCLK3 MAP3K11 TAF1 PRKG2 STK40 MAPK4 MAST3 | 7.58e-04 | 600 | 173 | 14 | GO:0004672 |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 9.36e-04 | 178 | 173 | 7 | GO:0015399 | |
| GeneOntologyMolecularFunction | kinase activity | SMG1 ABL1 RPS6KA3 LRRK1 AK7 CIITA PIK3C2G PIK3CB MAP4K1 DCLK3 MAP3K11 TAF1 PRKG2 STK40 MAPK4 MAST3 | 1.02e-03 | 764 | 173 | 16 | GO:0016301 |
| GeneOntologyBiologicalProcess | regulation of cardiac conduction | 4.06e-06 | 29 | 174 | 5 | GO:1903779 | |
| Domain | ATP_Ca_trans_C | 7.11e-09 | 4 | 173 | 4 | IPR022141 | |
| Domain | Alpha_amylase | 7.11e-09 | 4 | 173 | 4 | IPR006046 | |
| Domain | ATP_Ca_trans_C | 7.11e-09 | 4 | 173 | 4 | PF12424 | |
| Domain | Aamy_C | 7.11e-09 | 4 | 173 | 4 | SM00632 | |
| Domain | P-type_ATPase_IIB | 7.11e-09 | 4 | 173 | 4 | IPR006408 | |
| Domain | Alpha-amylase_C | 3.53e-08 | 5 | 173 | 4 | PF02806 | |
| Domain | A-amylase/branching_C | 3.53e-08 | 5 | 173 | 4 | IPR006048 | |
| Domain | Glyco_hydro_13_cat_dom | 2.44e-07 | 7 | 173 | 4 | IPR006047 | |
| Domain | Alpha-amylase | 2.44e-07 | 7 | 173 | 4 | PF00128 | |
| Domain | Aamy | 2.44e-07 | 7 | 173 | 4 | SM00642 | |
| Domain | A-amylase_C | 7.81e-07 | 3 | 173 | 3 | IPR031319 | |
| Domain | Cyt_c_oxidase_su7a | 3.10e-06 | 4 | 173 | 3 | IPR003177 | |
| Domain | Glyco_hydro_b | 8.96e-06 | 15 | 173 | 4 | IPR013780 | |
| Domain | ATPase_P-typ_TM_dom | 1.19e-05 | 16 | 173 | 4 | IPR023298 | |
| Domain | - | 1.19e-05 | 16 | 173 | 4 | 1.20.1110.10 | |
| Domain | Glyco_hydro_13 | 1.53e-05 | 6 | 173 | 3 | IPR015902 | |
| Domain | ATPase_P-typ_cation-transptr_C | 1.54e-05 | 17 | 173 | 4 | IPR006068 | |
| Domain | Cation_ATPase_C | 1.54e-05 | 17 | 173 | 4 | PF00689 | |
| Domain | Cation_ATPase_N | 1.97e-05 | 18 | 173 | 4 | PF00690 | |
| Domain | Cation_ATPase_N | 1.97e-05 | 18 | 173 | 4 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 2.47e-05 | 19 | 173 | 4 | IPR004014 | |
| Domain | LAM_G_DOMAIN | 2.52e-05 | 38 | 173 | 5 | PS50025 | |
| Domain | Laminin_G_2 | 3.26e-05 | 40 | 173 | 5 | PF02210 | |
| Domain | LamG | 5.22e-05 | 44 | 173 | 5 | SM00282 | |
| Domain | ATP2B1/4 | 8.53e-05 | 2 | 173 | 2 | IPR030319 | |
| Domain | Glycoside_hydrolase_SF | 1.29e-04 | 53 | 173 | 5 | IPR017853 | |
| Domain | EGF | 1.73e-04 | 126 | 173 | 7 | PF00008 | |
| Domain | Laminin_G | 1.98e-04 | 58 | 173 | 5 | IPR001791 | |
| Domain | - | 2.54e-04 | 3 | 173 | 2 | 4.10.91.10 | |
| Domain | DUF2465 | 2.54e-04 | 3 | 173 | 2 | PF10239 | |
| Domain | Uncharacterised_FAM98 | 2.54e-04 | 3 | 173 | 2 | IPR018797 | |
| Domain | - | 2.64e-04 | 14 | 173 | 3 | 2.60.40.1180 | |
| Domain | ATPase_P-typ_cyto_domN | 2.97e-04 | 35 | 173 | 4 | IPR023299 | |
| Domain | PI3/4_kinase_CS | 3.27e-04 | 15 | 173 | 3 | IPR018936 | |
| Domain | ATPase_P-typ_P_site | 3.32e-04 | 36 | 173 | 4 | IPR018303 | |
| Domain | P_typ_ATPase | 3.32e-04 | 36 | 173 | 4 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 3.32e-04 | 36 | 173 | 4 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 3.70e-04 | 37 | 173 | 4 | IPR008250 | |
| Domain | E1-E2_ATPase | 3.70e-04 | 37 | 173 | 4 | PF00122 | |
| Domain | - | 4.00e-04 | 16 | 173 | 3 | 1.10.1070.11 | |
| Domain | PI3Kc | 4.00e-04 | 16 | 173 | 3 | SM00146 | |
| Domain | Glyco_hydro_catalytic_dom | 4.10e-04 | 38 | 173 | 4 | IPR013781 | |
| Domain | Cadherin_CS | 5.33e-04 | 109 | 173 | 6 | IPR020894 | |
| Domain | PI3_PI4_kinase | 5.75e-04 | 18 | 173 | 3 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 5.75e-04 | 18 | 173 | 3 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 5.75e-04 | 18 | 173 | 3 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 5.75e-04 | 18 | 173 | 3 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 5.75e-04 | 18 | 173 | 3 | PS50290 | |
| Domain | CADHERIN_1 | 6.46e-04 | 113 | 173 | 6 | PS00232 | |
| Domain | Cadherin | 6.46e-04 | 113 | 173 | 6 | PF00028 | |
| Domain | CADHERIN_2 | 6.76e-04 | 114 | 173 | 6 | PS50268 | |
| Domain | - | 6.76e-04 | 114 | 173 | 6 | 2.60.40.60 | |
| Domain | CA | 7.08e-04 | 115 | 173 | 6 | SM00112 | |
| Domain | Cadherin-like | 7.41e-04 | 116 | 173 | 6 | IPR015919 | |
| Domain | Cadherin | 8.11e-04 | 118 | 173 | 6 | IPR002126 | |
| Domain | Quino_amine_DH_bsu | 1.06e-03 | 22 | 173 | 3 | IPR011044 | |
| Domain | ARM-type_fold | SMG1 DOHH USP9X NCBP1 CUL7 ARID1A HEATR6 PIK3C2G PIK3CB NIPBL | 1.27e-03 | 339 | 173 | 10 | IPR016024 |
| Domain | Kinase-like_dom | SMG1 ABL1 RPS6KA3 LRRK1 PIK3C2G PIK3CB MAP4K1 DCLK3 MAP3K11 PRKG2 STK40 MAPK4 MAST3 | 1.65e-03 | 542 | 173 | 13 | IPR011009 |
| Domain | - | 1.73e-03 | 93 | 173 | 5 | 1.10.533.10 | |
| Domain | PI3K_Ras-bd_dom | 1.74e-03 | 7 | 173 | 2 | IPR000341 | |
| Domain | S04_transporter_CS | 1.74e-03 | 7 | 173 | 2 | IPR018045 | |
| Domain | PI3K_rbd | 1.74e-03 | 7 | 173 | 2 | SM00144 | |
| Domain | PI3K_rbd | 1.74e-03 | 7 | 173 | 2 | PF00794 | |
| Domain | PI3K_RBD | 1.74e-03 | 7 | 173 | 2 | PS51546 | |
| Domain | - | 1.90e-03 | 95 | 173 | 5 | 2.60.120.200 | |
| Domain | DEATH | 1.94e-03 | 27 | 173 | 3 | SM00005 | |
| Domain | DEATH-like_dom | 2.28e-03 | 99 | 173 | 5 | IPR011029 | |
| Domain | PI3K_C2 | 2.30e-03 | 8 | 173 | 2 | SM00142 | |
| Domain | PI3K_C2_dom | 2.30e-03 | 8 | 173 | 2 | IPR002420 | |
| Domain | PI3K_C2 | 2.30e-03 | 8 | 173 | 2 | PF00792 | |
| Domain | PI3K_C2 | 2.30e-03 | 8 | 173 | 2 | PS51547 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_ | 4.50e-11 | 9 | 130 | 6 | M47622 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 2.73e-08 | 11 | 130 | 5 | M1091 | |
| Pathway | REACTOME_DIGESTION | 1.82e-06 | 23 | 130 | 5 | M27790 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 3.23e-06 | 12 | 130 | 4 | M27326 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 5.12e-06 | 28 | 130 | 5 | M27837 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 6.43e-06 | 14 | 130 | 4 | MM15052 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 7.88e-06 | 52 | 130 | 6 | M14171 | |
| Pathway | REACTOME_RHOV_GTPASE_CYCLE | 2.12e-05 | 37 | 130 | 5 | M41819 | |
| Pathway | REACTOME_RHOV_GTPASE_CYCLE | 2.12e-05 | 37 | 130 | 5 | MM15610 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 4.15e-05 | 8 | 130 | 3 | MM14717 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 1.03e-04 | 27 | 130 | 4 | MM15053 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 1.19e-04 | 28 | 130 | 4 | M924 | |
| Pathway | WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION | 3.24e-04 | 36 | 130 | 4 | M39831 | |
| Pubmed | 3.32e-12 | 5 | 178 | 5 | 6176569 | ||
| Pubmed | The human alpha-amylase multigene family consists of haplotypes with variable numbers of genes. | 1.98e-11 | 6 | 178 | 5 | 2788608 | |
| Pubmed | Regional assignment of human amylase (AMY) to p22----p21 of chromosome 1. | 1.98e-11 | 6 | 178 | 5 | 6608795 | |
| Pubmed | 1.98e-11 | 6 | 178 | 5 | 2452973 | ||
| Pubmed | 1.98e-11 | 6 | 178 | 5 | 15286789 | ||
| Pubmed | 1.98e-11 | 6 | 178 | 5 | 2081604 | ||
| Pubmed | 1.84e-10 | 8 | 178 | 5 | 12414807 | ||
| Pubmed | 4.11e-10 | 9 | 178 | 5 | 93520 | ||
| Pubmed | Low Copy Number of the AMY1 Locus Is Associated with Early-Onset Female Obesity in Finland. | 6.63e-10 | 4 | 178 | 4 | 26132294 | |
| Pubmed | Multiple polyadenylation sites in a mouse alpha-amylase gene. | 6.63e-10 | 4 | 178 | 4 | 6166922 | |
| Pubmed | Cell-specific expression of plasma membrane calcium ATPase isoforms in retinal neurons. | 6.63e-10 | 4 | 178 | 4 | 12209837 | |
| Pubmed | Electrophoretic variation of alpha-amylase in two inbred strains of Mus musculus. | 6.63e-10 | 4 | 178 | 4 | 4745489 | |
| Pubmed | 6.63e-10 | 4 | 178 | 4 | 3872721 | ||
| Pubmed | 6.63e-10 | 4 | 178 | 4 | 23413890 | ||
| Pubmed | Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. | 6.63e-10 | 4 | 178 | 4 | 8245032 | |
| Pubmed | A single mouse alpha-amylase gene specifies two different tissue-specific mRNAs. | 6.63e-10 | 4 | 178 | 4 | 6162570 | |
| Pubmed | Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. | 6.63e-10 | 4 | 178 | 4 | 7989379 | |
| Pubmed | Members of the Amy-2 alpha-amylase gene family of mouse strain CE/J contain duplicated 5' termini. | 6.63e-10 | 4 | 178 | 4 | 2987507 | |
| Pubmed | 6.63e-10 | 4 | 178 | 4 | 6091898 | ||
| Pubmed | 6.63e-10 | 4 | 178 | 4 | 6176715 | ||
| Pubmed | Mouse liver and salivary gland alpha-amylase mRNAs differ only in 5' non-translated sequences. | 6.63e-10 | 4 | 178 | 4 | 6162108 | |
| Pubmed | PMCA1 depletion in mouse eggs amplifies calcium signaling and impacts offspring growth†. | 6.63e-10 | 4 | 178 | 4 | 36130203 | |
| Pubmed | Expression of mouse Amy-2a alpha-amylase genes is regulated by strong pancreas-specific promoters. | 6.63e-10 | 4 | 178 | 4 | 3877171 | |
| Pubmed | Mouse alpha-amylase loci, Amy-1a and Amy-2a, are closely linked. | 6.63e-10 | 4 | 178 | 4 | 2989529 | |
| Pubmed | Independent regulation of nonallelic pancreatic amylase genes in diabetic mice. | 6.63e-10 | 4 | 178 | 4 | 6207174 | |
| Pubmed | 6.63e-10 | 4 | 178 | 4 | 10577388 | ||
| Pubmed | 6.63e-10 | 4 | 178 | 4 | 2410924 | ||
| Pubmed | Structural organization, ion transport, and energy transduction of P-type ATPases. | 6.63e-10 | 4 | 178 | 4 | 8634322 | |
| Pubmed | Genetic regulation of GM4(NeuAc) expression in mouse erythrocytes. | 6.63e-10 | 4 | 178 | 4 | 2332419 | |
| Pubmed | Characterization of the amino termini of mouse salivary and pancreatic amylases. | 6.63e-10 | 4 | 178 | 4 | 6165618 | |
| Pubmed | Structural forms of the human amylase locus and their relationships to SNPs, haplotypes and obesity. | 6.63e-10 | 4 | 178 | 4 | 26098870 | |
| Pubmed | 6.63e-10 | 4 | 178 | 4 | 12784250 | ||
| Pubmed | Genetic variation in mouse salivary amylase rate of synthesis. | 6.63e-10 | 4 | 178 | 4 | 94264 | |
| Pubmed | 6.63e-10 | 4 | 178 | 4 | 2476716 | ||
| Pubmed | Additional evidence for the close linkage of amy-1 and amy-2 in the mouse. | 6.63e-10 | 4 | 178 | 4 | 6163812 | |
| Pubmed | Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps. | 6.63e-10 | 4 | 178 | 4 | 11152753 | |
| Pubmed | 6.63e-10 | 4 | 178 | 4 | 16152770 | ||
| Pubmed | Developmental expression of the four plasma membrane calcium ATPase (Pmca) genes in the mouse. | 6.63e-10 | 4 | 178 | 4 | 10434059 | |
| Pubmed | 6.63e-10 | 4 | 178 | 4 | 2423416 | ||
| Pubmed | 6.63e-10 | 4 | 178 | 4 | 6161122 | ||
| Pubmed | 6.63e-10 | 4 | 178 | 4 | 6160849 | ||
| Pubmed | Gentic polymorphism of amylase isoenzymes in feral populations of the house mouse. | 6.63e-10 | 4 | 178 | 4 | 1141004 | |
| Pubmed | 6.63e-10 | 4 | 178 | 4 | 6157477 | ||
| Pubmed | 6.63e-10 | 4 | 178 | 4 | 15101689 | ||
| Pubmed | Simultaneous expression of salivary and pancreatic amylase genes in cultured mouse hepatoma cells. | 6.63e-10 | 4 | 178 | 4 | 2431276 | |
| Pubmed | 3.30e-09 | 5 | 178 | 4 | 6529441 | ||
| Pubmed | Murine Salivary Amylase Protects Against Streptococcus mutans-Induced Caries. | 3.30e-09 | 5 | 178 | 4 | 34276419 | |
| Pubmed | Genetic mapping of the IL-12 alpha chain gene (Il12a) on mouse chromosome 3. | 3.30e-09 | 5 | 178 | 4 | 8661735 | |
| Pubmed | 3.30e-09 | 5 | 178 | 4 | 1348427 | ||
| Pubmed | 3.30e-09 | 5 | 178 | 4 | 17938178 | ||
| Pubmed | 8.86e-09 | 30 | 178 | 6 | 6375655 | ||
| Pubmed | Purkinje cell degeneration associated with erythroid ankyrin deficiency in nb/nb mice. | 9.87e-09 | 6 | 178 | 4 | 1716634 | |
| Pubmed | Ampd-2 maps to distal mouse chromosome 3 in linkage with Ampd-1. | 9.87e-09 | 6 | 178 | 4 | 2328996 | |
| Pubmed | The mouse urate oxidase gene, Uox, maps to distal chromosome 3. | 9.87e-09 | 6 | 178 | 4 | 9250879 | |
| Pubmed | Cardiac excitation-contraction coupling in the absence of Na(+) - Ca2+ exchange. | 9.87e-09 | 6 | 178 | 4 | 12767889 | |
| Pubmed | A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis. | 9.87e-09 | 6 | 178 | 4 | 7859283 | |
| Pubmed | 9.87e-09 | 6 | 178 | 4 | 2002257 | ||
| Pubmed | 9.87e-09 | 6 | 178 | 4 | 2450406 | ||
| Pubmed | Genetics of hydroxyacid oxidase isozymes in the mouse: localisation of Hao-2 on linkage group XVI. | 9.87e-09 | 6 | 178 | 4 | 284003 | |
| Pubmed | 9.87e-09 | 6 | 178 | 4 | 7946325 | ||
| Pubmed | Linkage of the cadmium resistance locus to loci on mouse chromosome 12. | 9.87e-09 | 6 | 178 | 4 | 1021597 | |
| Pubmed | Analysis of the mouse Amy locus in recombinant inbred mouse strains. | 2.29e-08 | 7 | 178 | 4 | 2451911 | |
| Pubmed | 2.29e-08 | 7 | 178 | 4 | 6160178 | ||
| Pubmed | 2.29e-08 | 7 | 178 | 4 | 8666240 | ||
| Pubmed | Rostral cerebellar malformation, (rcm): a new recessive mutation on chromosome 3 of the mouse. | 2.29e-08 | 7 | 178 | 4 | 1401878 | |
| Pubmed | 2.29e-08 | 7 | 178 | 4 | 7949740 | ||
| Pubmed | 2.29e-08 | 7 | 178 | 4 | 8604219 | ||
| Pubmed | 2.69e-08 | 18 | 178 | 5 | 2338144 | ||
| Pubmed | 4.57e-08 | 8 | 178 | 4 | 2040456 | ||
| Pubmed | 4.57e-08 | 8 | 178 | 4 | 2824476 | ||
| Pubmed | Linkage relationships among eleven biochemical loci in Peromyscus. | 4.57e-08 | 8 | 178 | 4 | 6200103 | |
| Pubmed | 4.57e-08 | 8 | 178 | 4 | 3038891 | ||
| Pubmed | 4.57e-08 | 8 | 178 | 4 | 8486361 | ||
| Pubmed | Murine VCAM-1. Molecular cloning, mapping, and analysis of a truncated form. | 4.57e-08 | 8 | 178 | 4 | 7523515 | |
| Pubmed | 4.57e-08 | 8 | 178 | 4 | 10951186 | ||
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | USP9X ESD COPE NCBP1 FAM98A FAM98B YARS1 IQGAP1 BPNT1 IARS2 PIGR PA2G4 FUBP1 NUP133 FKBP4 GOT2 | 1.09e-07 | 607 | 178 | 16 | 39147351 |
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 32697825 | ||
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 6176528 | ||
| Pubmed | State and trait variance in salivary α-amylase: a behavioral genetic study. | 1.32e-07 | 3 | 178 | 3 | 21827821 | |
| Pubmed | Tissue-specific and insulin-dependent expression of a pancreatic amylase gene in transgenic mice. | 1.32e-07 | 3 | 178 | 3 | 2436036 | |
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 15299664 | ||
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 22063648 | ||
| Pubmed | An insulin-responsive element in the pancreatic enhancer of the amylase gene. | 1.32e-07 | 3 | 178 | 3 | 7678001 | |
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 1699843 | ||
| Pubmed | The structure of two distinct pancreatic amylase genes in mouse strain YBR. | 1.32e-07 | 3 | 178 | 3 | 2413838 | |
| Pubmed | Report of the Committee on the Genetic Constitution of Chromosome 1. | 1.32e-07 | 3 | 178 | 3 | 6360562 | |
| Pubmed | Two distinct pancreatic amylase genes are active in YBR mice. | 1.32e-07 | 3 | 178 | 3 | 6180955 | |
| Pubmed | Comparative genomic analysis of the mouse and rat amylase multigene family. | 1.32e-07 | 3 | 178 | 3 | 17223109 | |
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 8413315 | ||
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 6098446 | ||
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 30982860 | ||
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 12853116 | ||
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 12527308 | ||
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 2414282 | ||
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 28659346 | ||
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 25588701 | ||
| Pubmed | 1.36e-07 | 10 | 178 | 4 | 9121556 | ||
| Pubmed | 1.36e-07 | 10 | 178 | 4 | 2897103 | ||
| Pubmed | ABCC1 DSC1 ANK3 USP9X SEC31A CUL7 ARID1A IARS2 HEATR6 PIGR ISG15 PA2G4 FUBP1 MLH1 ATP2B4 FKBP4 | 1.96e-07 | 634 | 178 | 16 | 34591612 | |
| Pubmed | 2.13e-07 | 11 | 178 | 4 | 23449223 | ||
| Interaction | C17orf78 interactions | 2.58e-06 | 12 | 175 | 4 | int:C17orf78 | |
| Interaction | HSD17B6 interactions | 6.96e-06 | 15 | 175 | 4 | int:HSD17B6 | |
| Interaction | MAP4K1 interactions | 1.82e-05 | 130 | 175 | 8 | int:MAP4K1 | |
| Cytoband | 1p21 | 3.32e-08 | 24 | 178 | 5 | 1p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p21 | 6.40e-05 | 107 | 178 | 5 | chr1p21 | |
| GeneFamily | ATPases Ca2+ transporting | 1.78e-07 | 9 | 113 | 4 | 1209 | |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | ABCC1 HSPG2 ABL1 USP11 USP9X RPS6KA3 TOMM20 NCBP1 SEC31A PTBP1 LEPR YARS1 TBCB PPP1R8 PHKB PIK3CB MLH1 RBM5 GMPR VAV3 NUDC GNS FKBP4 MED12 GOT2 | 6.94e-06 | 1399 | 175 | 25 | M535 |
| Coexpression | GSE3982_DC_VS_NEUTROPHIL_LPS_STIM_UP | 8.13e-06 | 199 | 175 | 9 | M5391 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_COMMON_LYMPHOID_PROGENITOR_UP | 8.47e-06 | 200 | 175 | 9 | M8853 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 2.99e-05 | 27 | 175 | 4 | M14833 | |
| Coexpression | BERGER_MBD2_TARGETS | 4.64e-05 | 11 | 175 | 3 | MM905 | |
| Coexpression | MCCLUNG_CREB1_TARGETS_DN | 5.08e-05 | 60 | 175 | 5 | MM654 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA1_UP | 5.11e-05 | 143 | 175 | 7 | MM1056 | |
| Coexpression | GSE3982_MAC_VS_NKCELL_DN | 5.82e-05 | 198 | 175 | 8 | M5509 | |
| Coexpression | GSE17721_CTRL_VS_GARDIQUIMOD_6H_BMDC_DN | 6.03e-05 | 199 | 175 | 8 | M3787 | |
| Coexpression | GSE17721_LPS_VS_POLYIC_2H_BMDC_DN | 6.25e-05 | 200 | 175 | 8 | M3802 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 6.75e-05 | 33 | 175 | 4 | MM477 | |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_200 | 1.52e-05 | 177 | 173 | 9 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_200 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | USP9X ASH1L SEC31A SLC7A14 IQGAP1 NRXN1 DDX3Y GMPR ATP2B1 GNS | 6.72e-09 | 195 | 178 | 10 | 3e519cffa6144a62b06124642a14c9ff39b76554 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | USP9X ASH1L SEC31A SLC7A14 IQGAP1 NRXN1 DDX3Y GMPR ATP2B1 GNS | 6.72e-09 | 195 | 178 | 10 | 7796ea9247f4c63762f0de8490fed08b9717fa23 |
| ToppCell | wk_15-18-Epithelial-PNS-KCNIP4+_neuron|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.61e-08 | 179 | 178 | 9 | e20bfdfb6d5af8556eb66b81a19fbe4e3e28334a | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.01e-06 | 190 | 178 | 8 | f50b9814a1beac67dc042a8c27dfd085ceeda3a6 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.01e-06 | 190 | 178 | 8 | a22a510b4a257eb0eaf09c7ae7978d3d2f07a58c | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.01e-06 | 190 | 178 | 8 | 57c136bf6d7feafb4a220877bed0cc8fdf314db2 | |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | 1.27e-06 | 196 | 178 | 8 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.43e-06 | 199 | 178 | 8 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.43e-06 | 199 | 178 | 8 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | (5)_Fibroblast-D|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.43e-06 | 199 | 178 | 8 | 3f415620ad8b8d8c6871e1353e13f87b281fcc0e | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.48e-06 | 200 | 178 | 8 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.25e-06 | 148 | 178 | 7 | d5cace5605bff2bb8248fadb51f2dad7539930ba | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.94e-06 | 161 | 178 | 7 | e3327c296d48e821004e61a573abb75624a6f040 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.78e-06 | 185 | 178 | 7 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-05 | 186 | 178 | 7 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 189 | 178 | 7 | 29287525120be2953b76881ba3cfc4379c265e7a | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 189 | 178 | 7 | 7150dad9a92a715487c2d8130fa01b752ea69663 | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 189 | 178 | 7 | 6e4c0effd5192fd00052abc048fdb87a74fb6554 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 191 | 178 | 7 | 3387b95a3f2445c672d407922fdce3a91eabaef8 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 192 | 178 | 7 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 192 | 178 | 7 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 192 | 178 | 7 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 1.33e-05 | 194 | 178 | 7 | 55b97095a7a17a312c616703d291738a0f806339 | |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | 1.42e-05 | 196 | 178 | 7 | af206bb5bbb8b604a6212acd79878bcc3d326cec | |
| ToppCell | IPF-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 1.42e-05 | 196 | 178 | 7 | 7fc9894ceb79dab9f0495acc84e2d6d0d1c69bb7 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-05 | 196 | 178 | 7 | d74e899cc120146dded3a20716e22c7aca4f074a | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-05 | 196 | 178 | 7 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-05 | 196 | 178 | 7 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.47e-05 | 197 | 178 | 7 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | (5)_Fibroblast-I|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.47e-05 | 197 | 178 | 7 | eb486995ad72a0fbb6410c54e8dcf4ee780c0986 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Astrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.47e-05 | 197 | 178 | 7 | 5bcf963f21d23edafef1e90dc1de24cd3b0fccce | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.47e-05 | 197 | 178 | 7 | bd7e18a0fed085cfb8ed0e478d1f172a173febbe | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.47e-05 | 197 | 178 | 7 | 7e06aee2add54eeff4a9927d9b04b5797160113b | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_ALM_Sla|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.53e-05 | 132 | 178 | 6 | ddebc0b233fdbb73ceb70187945bbed8fd273f2a | |
| ToppCell | stromal_cell|World / Lineage and Cell class | 1.57e-05 | 199 | 178 | 7 | 507a82d0529b5b1fa5aebcfe43db53f0b6e3f8f0 | |
| ToppCell | stromal_cell-stromal_cell|World / Lineage and Cell class | 1.57e-05 | 199 | 178 | 7 | 74262363a34da3a1eb55ab375fd61ddd7bb39b23 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.57e-05 | 199 | 178 | 7 | dfc5c7a4a093baa7158dd8d4d29a870d9c469a3f | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.57e-05 | 199 | 178 | 7 | 9b2262edbdec89166d895ab97527e0ee5f9b6010 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.57e-05 | 199 | 178 | 7 | 251b3643dcd8f4645b17101bd716e66f12a20e88 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.57e-05 | 199 | 178 | 7 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 1.57e-05 | 199 | 178 | 7 | 211c3a08f2d484ab7a3368006767289088f0d957 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.57e-05 | 199 | 178 | 7 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.57e-05 | 199 | 178 | 7 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type | 1.57e-05 | 199 | 178 | 7 | 1a0add79f4e34078b3475eb11c85a4234bda197c | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.57e-05 | 199 | 178 | 7 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.57e-05 | 199 | 178 | 7 | 117f4f43b6c06dda553799b1063e827bce697370 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.57e-05 | 199 | 178 | 7 | c1760581c34b81d1d92c67500a1c8944e9cc6dad | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-4|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.62e-05 | 200 | 178 | 7 | 7642a14855589b0b3f68dbdc9e4d3fc7291854f7 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.62e-05 | 200 | 178 | 7 | 4dbe21cb63569f28c7017cda065ea5ee00d7254e | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-05 | 200 | 178 | 7 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.62e-05 | 200 | 178 | 7 | c5d818203bef80ff97c2e0158cf61970673dd258 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Fibroblasts|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.62e-05 | 200 | 178 | 7 | bfa73bc5f8a6c7de8353ca049a921ef19f7f4437 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-4|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.62e-05 | 200 | 178 | 7 | bde938e5a18844fb8cc1d1be5a086809f7e2b97d | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-4-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.62e-05 | 200 | 178 | 7 | 444c72334df421375ae6fc69b0adfd4950d49a43 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-4|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.62e-05 | 200 | 178 | 7 | 5826c17da67bdaba3a828792279004218d8260c8 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-05 | 200 | 178 | 7 | 6e3d1ae0ef84d3075afa40129a41169996462672 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-4|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.62e-05 | 200 | 178 | 7 | 8256511b099c3eab8e33194f90c9ff354e7cfe8e | |
| ToppCell | 356C-Fibroblasts|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.62e-05 | 200 | 178 | 7 | 9c95329f0b26ff378de803030d4c28517b3adc85 | |
| ToppCell | Skin-Fibroblasts|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 1.62e-05 | 200 | 178 | 7 | f777eadf571a1a6d246da87346a9cb9d511c2e81 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-05 | 200 | 178 | 7 | cb31cfcfa8e6d6cc610c4c22e97bc009dd8a9e7c | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.62e-05 | 200 | 178 | 7 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-05 | 200 | 178 | 7 | 3e0041c04e42a47257517dae8707a6454570c256 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-05 | 200 | 178 | 7 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.62e-05 | 200 | 178 | 7 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | Biopsy_IPF-Mesenchymal-Myofibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 1.62e-05 | 200 | 178 | 7 | c2c6f687c49ba790174b27c7b8b084af30b34c86 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.66e-05 | 134 | 178 | 6 | 64979e1a056b7406e1be39c5ebe2f8d731ac3c17 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Rrad|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.97e-05 | 138 | 178 | 6 | b3a040c5d0e1cc94d9b19155bca8700edba2d243 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Adamts2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.92e-05 | 156 | 178 | 6 | 2cd007b423c2395c5ce331902e7f27c805755eb3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.00e-05 | 163 | 178 | 6 | 2d6fd2562d78be9f83fa35d811eb7e27eb8cc5d1 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Col23a1_Adamts2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.92e-05 | 168 | 178 | 6 | 3fe432267656aff81b6d92c18d1b6fc0cde73d6a | |
| ToppCell | AT1-AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 6.53e-05 | 171 | 178 | 6 | 0b9912f07393aca889db72b40da08e0bc9bc1e8c | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.53e-05 | 171 | 178 | 6 | 2e43fb129ee9bdc3b31febc43c10f959bf0f4a7d | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.53e-05 | 171 | 178 | 6 | e219a1aa59a96e4bc3e2eacf985679174a51de41 | |
| ToppCell | -Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 6.96e-05 | 173 | 178 | 6 | 88be9182fbb1bc83531cd41e59ea57c112a21d54 | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.19e-05 | 174 | 178 | 6 | 2891ab2fd05eb4bbd239d1a2865f21ef7f2df39e | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.19e-05 | 174 | 178 | 6 | eade55f86ef1f7a5355ad65cec3aa6bfc5d3c62d | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 7.66e-05 | 176 | 178 | 6 | ce2c32b5ce0da848eb4da35ce4d215cdf74d9113 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.66e-05 | 176 | 178 | 6 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD163+CD14+_DCs|normal_Pleural_Fluid / Location, Cell class and cell subclass | 7.66e-05 | 176 | 178 | 6 | 7a74217b7fa1032b918f00a3972dff5fab74671a | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.66e-05 | 176 | 178 | 6 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.93e-05 | 181 | 178 | 6 | 58f76bb9ea1518c2b629a0256a3f6595a9278152 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL14A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.01e-04 | 185 | 178 | 6 | 506eee2c1b6e8acec3aa8b2c66868010006c4c14 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 185 | 178 | 6 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.04e-04 | 186 | 178 | 6 | 39e475a3c167b33daa63b0c1bfa32451c5f46635 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.04e-04 | 186 | 178 | 6 | 56c139e679d640ea901ead657a8e8887e0fca098 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-04 | 186 | 178 | 6 | 2fab7abed16a894afdd0207e86fc43a25a77fb9e | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-04 | 186 | 178 | 6 | ea2c8e0df038a00062d2098b4a9ac85141b9a728 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.04e-04 | 186 | 178 | 6 | 7c1807fca590cdccf7f5734460bac228d33964ca | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine-Neuroendocrine_L.0.7.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-04 | 186 | 178 | 6 | 714765585a644bf9817ab6eb3001b43b3c2d2410 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.04e-04 | 186 | 178 | 6 | 02418c50fdcca549bf73dedf6199ab4a27862a9b | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.07e-04 | 187 | 178 | 6 | f1d0fc625e0e7881b3f290742fd7148d995eb71e | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.07e-04 | 187 | 178 | 6 | 02e7246ef5ad41773d14426254e139b156d45c1d | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.07e-04 | 187 | 178 | 6 | 08c73d125e0638c9e9878165bba2442c266c8a48 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.10e-04 | 188 | 178 | 6 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.10e-04 | 188 | 178 | 6 | b382d18fb09fb2869f3c151efa71540a7f5ed229 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.10e-04 | 188 | 178 | 6 | e18065bbc26d6f3774fd1f478fb41d8fb555fa26 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 188 | 178 | 6 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | Endothelial-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.10e-04 | 188 | 178 | 6 | 0824d567356d360fd8e78e840c30529c139f98a1 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam_____kidney_distal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 188 | 178 | 6 | ab6fa1beff91584d9303c2a33735de89aae8d5cd | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-04 | 189 | 178 | 6 | d531399749409d614adca13d181830c6e3287508 | |
| Drug | AC1L88YH | 1.85e-15 | 17 | 176 | 9 | CID000374551 | |
| Drug | Bay e 4609 | 1.58e-11 | 16 | 176 | 7 | CID003085308 | |
| Drug | Glc)4 | 4.01e-11 | 10 | 176 | 6 | CID000189098 | |
| Drug | Ro 20-0083 | 4.01e-11 | 10 | 176 | 6 | CID003082332 | |
| Drug | AC1L3M0Q | 4.01e-11 | 10 | 176 | 6 | CID000118008 | |
| Drug | CNP-G5 | 8.76e-11 | 11 | 176 | 6 | CID000127309 | |
| Drug | R 623 | 1.55e-10 | 6 | 176 | 5 | CID003027594 | |
| Drug | 4,6-O-3-ketobutylidene maltopentaose | 1.55e-10 | 6 | 176 | 5 | CID003083414 | |
| Drug | dimethylaminomethylferrocene | 1.55e-10 | 6 | 176 | 5 | CID000102082 | |
| Drug | mono-6-deoxy-6-fluorocyclomaltoheptaose | 1.55e-10 | 6 | 176 | 5 | CID000127364 | |
| Drug | CNP-G3 | 1.55e-10 | 6 | 176 | 5 | CID003082910 | |
| Drug | CaCl2 | AMY1A AMY1B AMY1C AMY2A AMY2B VPS39 ADCY2 ACTL7B MMP2 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 2.69e-10 | 156 | 176 | 13 | CID000024854 |
| Drug | methyl 1'-epiacarviosin | 3.21e-10 | 13 | 176 | 6 | CID000197426 | |
| Drug | isoacarbose | 3.21e-10 | 13 | 176 | 6 | CID000449165 | |
| Drug | AC1L5BOU | 5.41e-10 | 7 | 176 | 5 | CID000174858 | |
| Drug | 3KBG5CNP | 5.41e-10 | 7 | 176 | 5 | CID003083250 | |
| Drug | BG5P | 5.41e-10 | 7 | 176 | 5 | CID003082752 | |
| Drug | 2-chloro-4-nitrophenol | 5.59e-10 | 14 | 176 | 6 | CID000012074 | |
| Drug | 4-nitrophenylmaltoheptaoside | 9.25e-10 | 15 | 176 | 6 | CID000173254 | |
| Drug | desethylaprophen | 1.43e-09 | 8 | 176 | 5 | CID000163919 | |
| Drug | azintamide | 1.43e-09 | 8 | 176 | 5 | CID000071105 | |
| Drug | alpha-maltosyl fluoride | 3.20e-09 | 9 | 176 | 5 | CID000194237 | |
| Drug | trestatin A | 3.20e-09 | 9 | 176 | 5 | CID003054994 | |
| Drug | N-PMT | 3.45e-09 | 4 | 176 | 4 | CID000194224 | |
| Drug | AC1MQT4V | 3.45e-09 | 4 | 176 | 4 | CID003482066 | |
| Drug | SAIB-SG | 3.45e-09 | 4 | 176 | 4 | CID002735139 | |
| Drug | 2-nitropropyl acetate | 3.45e-09 | 4 | 176 | 4 | CID013573844 | |
| Drug | Dembrexine | 3.45e-09 | 4 | 176 | 4 | CID000072009 | |
| Drug | g lw | 3.45e-09 | 4 | 176 | 4 | CID000444139 | |
| Drug | beta-santalene | 3.45e-09 | 4 | 176 | 4 | CID000010534 | |
| Drug | AC1LAC07 | 6.37e-09 | 10 | 176 | 5 | CID000485275 | |
| Drug | trans-cinnamamide | 6.37e-09 | 10 | 176 | 5 | CID000012135 | |
| Drug | CG-120 | 6.37e-09 | 10 | 176 | 5 | CID000171403 | |
| Drug | validamycin D | 1.16e-08 | 11 | 176 | 5 | CID000166726 | |
| Drug | FG5P | 1.16e-08 | 11 | 176 | 5 | CID000127486 | |
| Drug | HgI2 | 1.16e-08 | 11 | 176 | 5 | CID000024485 | |
| Drug | 2C KM | 1.16e-08 | 11 | 176 | 5 | CID009549196 | |
| Drug | maltosaccharide | 1.32e-08 | 22 | 176 | 6 | CID005461034 | |
| Drug | Deposiston | 1.72e-08 | 5 | 176 | 4 | CID003080829 | |
| Drug | 2-[[(2-amino-1,3-thiazol-4-yl)-(2-oxoethylcarbamoyl)methylidene]amino]oxy-2-methyl-propanoic Acid | 1.72e-08 | 5 | 176 | 4 | CID010358258 | |
| Drug | lunularic acid | 1.72e-08 | 5 | 176 | 4 | CID000161413 | |
| Drug | himachalene | 1.72e-08 | 5 | 176 | 4 | CID000015095 | |
| Drug | actinidine | 1.72e-08 | 5 | 176 | 4 | CID000068231 | |
| Drug | 2TAA | 1.72e-08 | 5 | 176 | 4 | CID000127374 | |
| Drug | cimicifugic acid A | 1.72e-08 | 5 | 176 | 4 | CID006449879 | |
| Drug | silver perchlorate | 1.72e-08 | 5 | 176 | 4 | CID000024562 | |
| Drug | AC1L4DZ4 | 1.72e-08 | 5 | 176 | 4 | CID000155287 | |
| Drug | azaprophen | 1.98e-08 | 12 | 176 | 5 | CID000129486 | |
| Drug | Panose B | 2.35e-08 | 24 | 176 | 6 | CID000439297 | |
| Drug | 8a-c | 3.19e-08 | 13 | 176 | 5 | CID000066085 | |
| Drug | maltal | 3.19e-08 | 13 | 176 | 5 | CID000169427 | |
| Drug | oxalate | SLC26A3 AMY1A AMY1B AMY1C AMY2A AMY2B ACOX3 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 4.33e-08 | 158 | 176 | 11 | CID000000971 |
| Drug | Cyclodextrins | 4.93e-08 | 14 | 176 | 5 | CID000024238 | |
| Drug | pH10 | 4.93e-08 | 14 | 176 | 5 | CID000478568 | |
| Drug | terephthaloyl chloride | 4.93e-08 | 14 | 176 | 5 | CID000007488 | |
| Drug | 2-amino-6-picoline | 5.11e-08 | 6 | 176 | 4 | CID000015765 | |
| Drug | phenol blue | 5.11e-08 | 6 | 176 | 4 | CID000075078 | |
| Drug | Gu-4 | 5.11e-08 | 6 | 176 | 4 | CID000448679 | |
| Drug | Borane dimethylamine complex | 5.11e-08 | 6 | 176 | 4 | CID009898794 | |
| Drug | AC1L3OV4 | 5.11e-08 | 6 | 176 | 4 | CID000092801 | |
| Drug | (2S)-2-acetamido-3-[(3E)-3-[(4-arsonophenyl)hydrazono]-4-oxo-cyclohexa-1,5-dien-1-yl]propanoic acid | 5.11e-08 | 6 | 176 | 4 | CID009577343 | |
| Drug | AC1OAGH8 | 5.11e-08 | 6 | 176 | 4 | CID006857368 | |
| Drug | vermella | 5.11e-08 | 6 | 176 | 4 | CID000203726 | |
| Drug | hymenin | 5.11e-08 | 6 | 176 | 4 | CID000010499 | |
| Drug | mercuric thiocyanate | 5.11e-08 | 6 | 176 | 4 | CID000011615 | |
| Drug | 2ai8 | 7.35e-08 | 15 | 176 | 5 | CID005289329 | |
| Drug | DABITC | 7.35e-08 | 15 | 176 | 5 | CID000082084 | |
| Drug | gamma-cyclodextrin | 1.06e-07 | 16 | 176 | 5 | CID000086575 | |
| Drug | methyl blue | 1.19e-07 | 7 | 176 | 4 | CID011969534 | |
| Drug | AC1L9UU3 | 1.19e-07 | 7 | 176 | 4 | CID000071762 | |
| Drug | Paramax | 1.19e-07 | 7 | 176 | 4 | CID000156411 | |
| Drug | amino-methyl | 1.19e-07 | 7 | 176 | 4 | CID000142005 | |
| Drug | AC1NS1E4 | 1.23e-07 | 31 | 176 | 6 | CID005326963 | |
| Drug | amylopectin | 1.46e-07 | 52 | 176 | 7 | CID000439207 | |
| Drug | lycopene | RPS6KA3 CRB1 PAH MLH1 CYP7B1 MMP2 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 1.74e-07 | 143 | 176 | 10 | ctd:C015329 |
| Drug | trimitan | 2.06e-07 | 18 | 176 | 5 | CID000005561 | |
| Drug | aprophen | 2.06e-07 | 18 | 176 | 5 | CID000071128 | |
| Drug | boric acid gel | 2.36e-07 | 8 | 176 | 4 | CID003016474 | |
| Drug | AC1NSVJM | 2.36e-07 | 8 | 176 | 4 | CID005317411 | |
| Drug | N-vinylcaprolactam | 2.36e-07 | 8 | 176 | 4 | CID000075227 | |
| Drug | 9-azidoacridine | 2.36e-07 | 8 | 176 | 4 | CID000146692 | |
| Drug | acrinor | 2.36e-07 | 8 | 176 | 4 | CID005489637 | |
| Drug | NSC300622 | 2.36e-07 | 8 | 176 | 4 | CID000028426 | |
| Drug | theodrenaline | 2.36e-07 | 8 | 176 | 4 | CID000071857 | |
| Drug | rhodanile blue | 2.36e-07 | 8 | 176 | 4 | CID000073372 | |
| Drug | AC1L9MQJ | 2.78e-07 | 19 | 176 | 5 | CID000449108 | |
| Drug | toxaphene | 3.16e-07 | 58 | 176 | 7 | CID005284469 | |
| Drug | AC1LA2MZ | 3.16e-07 | 58 | 176 | 7 | CID000460551 | |
| Drug | BCDs | 3.73e-07 | 37 | 176 | 6 | CID000364214 | |
| Drug | GSAD | 4.22e-07 | 9 | 176 | 4 | CID009909127 | |
| Drug | GU-3 | 4.22e-07 | 9 | 176 | 4 | CID000448687 | |
| Drug | zingiberene | 4.22e-07 | 9 | 176 | 4 | CID000092776 | |
| Drug | Atonik | 4.22e-07 | 9 | 176 | 4 | CID000069471 | |
| Drug | H 187 | 4.22e-07 | 9 | 176 | 4 | CID000001742 | |
| Drug | mercuric nitrate | 4.22e-07 | 9 | 176 | 4 | CID000024864 | |
| Drug | AC1N3UXZ | 4.54e-07 | 3 | 176 | 3 | CID004118625 | |
| Drug | AC1L3XPY | 4.80e-07 | 21 | 176 | 5 | CID000124005 | |
| Drug | potassium thiocyanate solution | 4.80e-07 | 21 | 176 | 5 | CID010931372 | |
| Drug | maltohexaose | 5.17e-07 | 39 | 176 | 6 | CID000439606 | |
| Drug | S-p-nitrobenzyloxycarbonylglutathione | 5.17e-07 | 39 | 176 | 6 | CID004632704 | |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 1.70e-08 | 6 | 173 | 4 | DOID:0050429 (implicated_via_orthology) | |
| Disease | alpha-amylase 1 measurement | 1.41e-07 | 9 | 173 | 4 | EFO_0801371 | |
| Disease | Failure to Thrive | 3.91e-06 | 6 | 173 | 3 | C0015544 | |
| Disease | Malignant neoplasm of breast | FNDC3B ABCC1 NID2 KIF6 ABL1 ANK2 VPS39 RPS6KA3 PCDHB15 SIM1 ARID1A LEPR PHKB HOXB9 PIK3CB NUP133 MMP2 NIPBL MED12 | 1.93e-05 | 1074 | 173 | 19 | C0006142 |
| Disease | Deafness, Autosomal Recessive 12 | 3.42e-05 | 2 | 173 | 2 | C1832394 | |
| Disease | Autosomal recessive nonsyndromic hearing loss 12 | 3.42e-05 | 2 | 173 | 2 | cv:C1832394 | |
| Disease | autosomal recessive nonsyndromic deafness 12 (is_implicated_in) | 3.42e-05 | 2 | 173 | 2 | DOID:0110467 (is_implicated_in) | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE 12 | 3.42e-05 | 2 | 173 | 2 | 601386 | |
| Disease | cytochrome-c oxidase deficiency disease (implicated_via_orthology) | 1.27e-04 | 17 | 173 | 3 | DOID:3762 (implicated_via_orthology) | |
| Disease | Hypertensive disease | 1.36e-04 | 190 | 173 | 7 | C0020538 | |
| Disease | Drug toxicity | 1.39e-04 | 84 | 173 | 5 | C0013221 | |
| Disease | Adverse reaction to drug | 1.39e-04 | 84 | 173 | 5 | C0041755 | |
| Disease | Antihypertensive use measurement | 1.80e-04 | 265 | 173 | 8 | EFO_0009927 | |
| Disease | Monogenic Non-Syndromic Obesity, Autosomal Recessive | 2.03e-04 | 4 | 173 | 2 | cv:CN043636 | |
| Disease | age at menarche | PCSK1 SEMA6C USP49 FNDC3B SIM1 ARID1A LEPR RMI1 ZBTB46 SLIT3 GAN MAST3 | 2.14e-04 | 594 | 173 | 12 | EFO_0004703 |
| Disease | Adenocarcinoma of large intestine | 2.60e-04 | 96 | 173 | 5 | C1319315 | |
| Disease | Leber congenital amaurosis (is_implicated_in) | 5.05e-04 | 6 | 173 | 2 | DOID:14791 (is_implicated_in) | |
| Disease | Bone Diseases, Developmental | 5.22e-04 | 27 | 173 | 3 | C0005941 | |
| Disease | testosterone measurement | PCSK1 NRDE2 ANK2 ANK3 ARID1A LEPR IQGAP1 FBXO38 RMI1 RGS14 PTPN9 NRXN1 NUDC ATP2B2 ATP2B4 ZNF654 FKBP4 MED12 | 5.26e-04 | 1275 | 173 | 18 | EFO_0004908 |
| Disease | Usher syndrome | 7.04e-04 | 7 | 173 | 2 | cv:C0271097 | |
| Disease | progressive supranuclear palsy | 7.89e-04 | 31 | 173 | 3 | MONDO_0019037 | |
| Disease | Mental Retardation, X-Linked 1 | 8.67e-04 | 32 | 173 | 3 | C2931498 | |
| Disease | diastolic blood pressure, self reported educational attainment | 9.35e-04 | 8 | 173 | 2 | EFO_0004784, EFO_0006336 | |
| Disease | X-13684 measurement | 9.35e-04 | 8 | 173 | 2 | EFO_0800737 | |
| Disease | cancer (implicated_via_orthology) | 1.07e-03 | 268 | 173 | 7 | DOID:162 (implicated_via_orthology) | |
| Disease | body fat distribution | 1.27e-03 | 202 | 173 | 6 | EFO_0004341 | |
| Disease | Breast Carcinoma | 1.35e-03 | 538 | 173 | 10 | C0678222 | |
| Disease | response to anticonvulsant | 1.60e-03 | 85 | 173 | 4 | GO_0036277 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.92e-03 | 42 | 173 | 3 | EFO_0008317, EFO_0008596, EFO_0020945 | |
| Disease | glioblastoma (is_marker_for) | 2.20e-03 | 44 | 173 | 3 | DOID:3068 (is_marker_for) | |
| Disease | cholangiocarcinoma (biomarker_via_orthology) | 2.55e-03 | 13 | 173 | 2 | DOID:4947 (biomarker_via_orthology) | |
| Disease | hyperglycemia (is_marker_for) | 2.55e-03 | 13 | 173 | 2 | DOID:4195 (is_marker_for) | |
| Disease | epilepsy (implicated_via_orthology) | 2.80e-03 | 163 | 173 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | Diabetic Neuralgia | 2.97e-03 | 14 | 173 | 2 | C0751074 | |
| Disease | Diabetic Neuropathies | 2.97e-03 | 14 | 173 | 2 | C0011882 | |
| Disease | Asymmetric Diabetic Proximal Motor Neuropathy | 2.97e-03 | 14 | 173 | 2 | C0271674 | |
| Disease | Symmetric Diabetic Proximal Motor Neuropathy | 2.97e-03 | 14 | 173 | 2 | C0271673 | |
| Disease | Diabetic Mononeuropathy | 2.97e-03 | 14 | 173 | 2 | C0271678 | |
| Disease | Diabetic Autonomic Neuropathy | 2.97e-03 | 14 | 173 | 2 | C0271686 | |
| Disease | Diabetic Amyotrophy | 2.97e-03 | 14 | 173 | 2 | C0271685 | |
| Disease | Diabetic Polyneuropathies | 2.97e-03 | 14 | 173 | 2 | C0271680 | |
| Disease | Diabetic Asymmetric Polyneuropathy | 2.97e-03 | 14 | 173 | 2 | C0393835 | |
| Disease | Testicular Germ Cell Tumor | 2.97e-03 | 14 | 173 | 2 | C1336708 | |
| Disease | Weight Gain | 3.10e-03 | 102 | 173 | 4 | C0043094 | |
| Disease | Retinitis Pigmentosa | 3.33e-03 | 104 | 173 | 4 | C0035334 | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 3.36e-03 | 51 | 173 | 3 | cv:CN043650 | |
| Disease | high grade glioma (biomarker_via_orthology) | 3.41e-03 | 15 | 173 | 2 | DOID:3070 (biomarker_via_orthology) | |
| Disease | hemoglobin A1 measurement | 3.72e-03 | 520 | 173 | 9 | EFO_0007629 | |
| Disease | focal segmental glomerulosclerosis | 3.89e-03 | 16 | 173 | 2 | EFO_0004236 | |
| Disease | Leber congenital amaurosis | 3.89e-03 | 16 | 173 | 2 | cv:C0339527 | |
| Disease | phenylalanine measurement | 4.16e-03 | 55 | 173 | 3 | EFO_0005001 | |
| Disease | hyperglycemia (implicated_via_orthology) | 4.39e-03 | 17 | 173 | 2 | DOID:4195 (implicated_via_orthology) | |
| Disease | hypertrophic cardiomyopathy (is_marker_for) | 4.39e-03 | 17 | 173 | 2 | DOID:11984 (is_marker_for) | |
| Disease | neuritic plaque measurement | 4.67e-03 | 349 | 173 | 7 | EFO_0006798 | |
| Disease | glycoprotein measurement | 5.37e-03 | 119 | 173 | 4 | EFO_0004555 | |
| Disease | laryngeal squamous cell carcinoma (is_marker_for) | 5.47e-03 | 19 | 173 | 2 | DOID:2876 (is_marker_for) | |
| Disease | cytomegalovirus virus reactivation, response to allogeneic hematopoietic stem cell transplant | 5.47e-03 | 19 | 173 | 2 | EFO_0007044, EFO_0020106 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LLFLKSGQGEPLDDY | 11 | Q02325 | |
| PEGLFISKLLGEYEV | 311 | Q8NAT2 | |
| YPGSQLDILIDQGKD | 211 | P10768 | |
| PGKNAIDVTYLLEEG | 2936 | Q9NR48 | |
| YKILGIPSGANEDEI | 6 | O75953 | |
| YELPDGKLITIGQER | 281 | Q9Y614 | |
| TLGYEDLDELQKEPQ | 131 | Q9NZN9 | |
| LDSPIGRADGELYKN | 651 | O15254 | |
| EGGYLELLNSDADPL | 31 | P33076 | |
| LEPGDEVYIKLDGGK | 221 | Q5VWW1 | |
| SKPFIYQEVIDLGGE | 241 | P0DTE7 | |
| SKPFIYQEVIDLGGE | 241 | P0DTE8 | |
| EGLLQEALDKDSGYP | 236 | O14579 | |
| SKPFIYQEVIDLGGE | 241 | P0DUB6 | |
| GGLITLALPLDYKQE | 741 | Q9NYQ6 | |
| QEDDEIPLYLKGGVA | 36 | P14406 | |
| SKPFIYQEVIDLGGE | 241 | P19961 | |
| VDPLDGTKEYTEGLL | 116 | O95861 | |
| VDPDKGLNGLVTYTL | 2321 | Q9H251 | |
| EDGVVRILELYDPKG | 536 | Q96MT7 | |
| QEDDGIPLYLKGGIA | 36 | O60397 | |
| DNDIPLYLKGGIVDN | 36 | P24310 | |
| GAIGDPEVLEILKQY | 96 | Q9BU89 | |
| AQVKYGDLLPADGIL | 216 | P20020 | |
| GDIAQVKYGDLLPAD | 211 | Q01814 | |
| IAQVKYGDLLPADGV | 216 | Q16720 | |
| IAQVKYGDLLPADGI | 211 | P23634 | |
| PDAGEDELLKIIGNL | 1176 | P46940 | |
| DDIKGIQELYGASPD | 436 | P08253 | |
| EDSEADRPKGLIGYV | 81 | Q9ULW6 | |
| VDTLESEYLKIPGDQ | 116 | P98160 | |
| GEKPNGEINSILLDY | 301 | Q5T6V5 | |
| DPLGQTEKIYVLDGT | 161 | Q9NRN5 | |
| LYAGLPELSGIQDLK | 1121 | O75747 | |
| LPENLGGYVKIDLAT | 231 | P43378 | |
| LKEYEVGDPGQRTLL | 1731 | O14497 | |
| GDGGEYLRPEDLKEL | 856 | Q01484 | |
| SKPFIYQEVIDLGGE | 241 | P04746 | |
| LDVQSGADGIKYPEL | 211 | Q9Y5G9 | |
| PLKSDQDYILKEGDL | 91 | Q9UQ80 | |
| YIAKGEDEELLTVNP | 481 | Q8N543 | |
| ELSKLTNDIEELGPY | 12321 | Q8WXI7 | |
| DGIQLSEYLPEVKDL | 1111 | Q8WUM0 | |
| DGGISDNLPLYELKN | 166 | Q96AD5 | |
| GTENEELLKDPLYIG | 196 | P48163 | |
| EGLAGVLEADLPNYK | 51 | Q09161 | |
| EKGQLLSIPAAYGDL | 86 | Q38SD2 | |
| IDYARQLIEEKIGGP | 436 | Q96AE4 | |
| YEVLGPKGTDLQGEL | 81 | P31152 | |
| LKNPEEGQSEGSYLL | 236 | Q6ZP29 | |
| YRDLKPENILLDEEG | 191 | P51812 | |
| FEGKPLEDQLPLGEY | 126 | P05161 | |
| APEILSEKGYGLEVD | 521 | Q9C098 | |
| SLLIPDFGKLEEGTY | 311 | O14498 | |
| KYDTVLKDEEPGDGL | 306 | Q9BRR8 | |
| IKLGLGVDEYDPTAN | 291 | Q58FG0 | |
| EGYGPAGKILLDLEQ | 626 | Q14999 | |
| SKVPLLAEIYGIEGN | 66 | Q8TET4 | |
| FGDDDEIPQELLLGK | 1221 | Q6KC79 | |
| SPGLYAIEEGEQEKR | 341 | Q9H7Z3 | |
| KDDILYVDDTLPQGT | 1616 | Q8TDM6 | |
| IEPGEDDKYNIGIIE | 31 | Q8WVE0 | |
| LEELGTGLIQQYKPD | 736 | Q6AI08 | |
| QGIYSIDEDEKLIPS | 21 | Q6ZMV9 | |
| DVGDEDLLPGYLNDI | 281 | O60662 | |
| ELSQLLKDIDGYGGI | 26 | P00709 | |
| LKDIDGYGGIALPEL | 31 | P00709 | |
| GLDELLKLEGNFPEE | 1056 | P48357 | |
| EKIEGTLGVLYDQPR | 716 | Q93074 | |
| ELKLDGNPITEDEYL | 201 | Q96PP9 | |
| GPLETEEYRLDKEGL | 51 | O75023 | |
| ALEEYAERLQKAGPG | 321 | Q96FB5 | |
| ILDLDDELYLGGLPE | 606 | Q9ULB1 | |
| DELYLGGLPENKAGL | 611 | Q9ULB1 | |
| GDGRKYPELVLDTEL | 186 | Q9Y5E8 | |
| NTGEEGEYFLKVLIP | 26 | Q9UNW9 | |
| GDEENPLKRGLVAAY | 606 | P52756 | |
| LLFLKSGQGEPLDDY | 11 | Q15195 | |
| LGGPAQLTDEEKYRD | 1261 | P09884 | |
| DLKPENLILDAEGYL | 576 | Q13237 | |
| IGLASLGAPDEYIEK | 306 | P00439 | |
| GELLKQGTPEYSLET | 126 | P17482 | |
| DPDLGKNGLVSYELL | 471 | Q9H158 | |
| YEEVKRGALPSGELN | 166 | Q14112 | |
| DLVKYGLADVVENPG | 371 | Q6PIJ6 | |
| EKGELGLSLPYGIQV | 366 | A8MW95 | |
| VEEGDGDIRDPYLKQ | 441 | Q08462 | |
| GIDGEPEKVYTNDIL | 1241 | Q9C0G6 | |
| PQVLSKLGELYDREG | 586 | Q13099 | |
| LQELKEIFGENGYPD | 36 | A0A1W2PPK0 | |
| PKDNGGSEILKYLLE | 596 | Q53EP0 | |
| LYILGGEDGEKELIS | 376 | Q9H2C0 | |
| LEPASELGEDLLKLY | 186 | Q5XKL5 | |
| GKLLDYLQENPKGLD | 66 | O95999 | |
| LLPGIYEIKTENGDL | 2526 | A8TX70 | |
| ATDIDKNGYPDLIVG | 441 | P06756 | |
| PGIDLSQVYELLEKD | 441 | P00519 | |
| DLPYDGDLSQIKIGN | 16 | Q5T1N1 | |
| GLDLVPKGLYQDLED | 321 | Q8NDY3 | |
| DKYLGPQDLKELGDD | 881 | Q12955 | |
| NLYEAPEELLADGEG | 231 | O43281 | |
| EALGYKGPLLEEQAL | 21 | Q52LJ0 | |
| NIDLGPTILDIAGYD | 371 | P15586 | |
| QYIIGQLGLAKDPLE | 316 | O60307 | |
| PVAIIELELGKYGQE | 141 | Q8N668 | |
| AGQELLGYKALDPEI | 486 | Q08554 | |
| LDPEISSGEGLRYQK | 496 | Q08554 | |
| EELPDERESGLLGYQ | 466 | Q7Z7F0 | |
| DLEIIDDKPIGLNYS | 471 | O75881 | |
| EIGEGENLDLPYGLE | 191 | Q02790 | |
| PYKGDVENTILDILG | 296 | P36959 | |
| YIGGLPDKQETELNG | 831 | P82279 | |
| ILSQIYTDGPGEALK | 236 | O15523 | |
| YQVKLTLDSEEEGPL | 321 | Q8NFF5 | |
| ADPEAGLLLYLKTGQ | 326 | P51530 | |
| EKGLAPEVADRIGDY | 256 | P12081 | |
| LSEPLGGKLLEEYTQ | 101 | Q86X76 | |
| DYEPSGQDELALRKG | 51 | Q16584 | |
| ALGTGFLYLPKDEEE | 151 | Q3KNS1 | |
| ELQIRGGDKPALDLY | 886 | Q93100 | |
| DKGEIQEYGAPSDLL | 1501 | P33527 | |
| PEVAAVALKGGYNEL | 181 | Q92918 | |
| GGYIPKTNEELLRDL | 401 | Q8IZ73 | |
| LDSLEQYVKGDLLEG | 1751 | Q93008 | |
| LPSGEEGEYVLALKQ | 51 | Q9BT43 | |
| LSGLLYPGLQALDEE | 161 | P54577 | |
| GEIIKLIADYSPDDI | 161 | Q17RP2 | |
| EGDLLKDQRGSPAYI | 226 | Q8N2I9 | |
| PLKRDYGVQLVEEGA | 131 | Q9P015 | |
| KDPDGTLIIELYGDN | 1131 | O60522 | |
| KGLLGLPEEETELDN | 151 | Q12972 | |
| VGDGETKEPFLLVQY | 51 | O75324 | |
| GQPEKVGLLLEYEAQ | 146 | Q8WW59 | |
| DGILEIPKGELNGFY | 71 | Q9H9A7 | |
| GDLILAEYSEENGPL | 676 | P21675 | |
| LGKLPETDVYIDIDA | 511 | P58743 | |
| LESLEDLGYKGPLLE | 11 | Q8NCA5 | |
| PGISLKVGDLNRDYE | 161 | Q5QGS0 | |
| VGAALYEGLAEELKP | 256 | Q9HAZ2 | |
| PKLDGSLDEYLSLQE | 2486 | Q96Q15 | |
| ELTGYEPQDLIEKTL | 251 | P81133 | |
| TDEDIYLLGKATLPG | 386 | P15907 | |
| PKLEEYIQDELGGKI | 101 | Q96LZ7 | |
| KEVLSEVGGPDALEY | 576 | Q9NSE4 | |
| DYPLDGNQELIALGL | 366 | P40879 | |
| EPSIPENLEDKLYGG | 181 | P42338 | |
| DGPKEGLAEYIVEFL | 601 | P40692 | |
| LLFLKSGQGEPLDDY | 11 | P00747 | |
| LKGQPAIIDGELYNE | 211 | Q9Y266 | |
| DSPRDEGKLLIGYEN | 216 | Q9Y2K9 | |
| LGETYGEKEDPEGLQ | 171 | Q15399 | |
| LQGIADYRPKDGETI | 406 | P20062 | |
| NLDKEYLPIGGLAEF | 91 | P00505 | |
| GKGEESYPDLLALLI | 181 | Q8TBB6 | |
| DNGILLYKGDNDPLA | 1191 | O75094 | |
| GDNIPKILVFTEDGY | 81 | Q5JS37 | |
| KLDQEDALLGSYPVD | 66 | Q99426 | |
| EPDVLKDELQLYGDA | 106 | Q8WWA1 | |
| KDELQLYGDAPGEVV | 111 | Q8WWA1 | |
| PLAEIDGIELTYGIK | 826 | P24821 | |
| DYVLNDNPEGDLKLL | 81 | Q70CQ1 | |
| GRDEFYEEPLKDILG | 121 | Q8IZM8 | |
| LQAEEEGEGLVPNKY | 86 | Q9H3T2 | |
| PLLEEFLQEGLEKGD | 71 | Q53EL9 | |
| GLSLPDIKVYLVGNE | 336 | O43566 | |
| PGLLNDTKVYTVDLG | 131 | P01833 | |
| KAQYEGRLSLLEEPG | 406 | P01833 | |
| LLAGEGPDVLVYSLD | 31 | Q9NNW5 | |
| YLTENDLEESPKGGL | 506 | Q63HK5 | |
| RLEIYLEPLKDAGDG | 46 | Q5T4F4 | |
| YGERLKELSENGAPE | 521 | Q8N5H7 | |
| VTGLEAKEDLYLEPQ | 66 | Q8IWB9 | |
| GNIILYDPSKIIAGD | 96 | O94979 | |
| LPREGQEDQGLTKDY | 416 | P26599 | |
| KEGLVEGEDYVLLPA | 146 | P51784 | |
| LGEELLAQGEYEKGV | 76 | Q15388 | |
| DVLGDDGSLLFEYLP | 386 | Q86UZ6 | |
| GEEEGELGEYRQKLL | 651 | Q96JC1 | |
| YKGLPDLIDETLVED | 141 | Q9UKW4 | |
| LIKEIGEPRNYGLTD | 601 | Q96M32 | |
| LYSEGDPGEKLELVA | 336 | Q96BF6 | |
| VILKEPGLEDLGTYS | 956 | Q5VTT5 | |
| EELGYDLLGQIGSLE | 51 | P29120 | |
| NPGLDGIIEYDDFKL | 6 | Q00653 |